Get started
Hologic, Inc.Hologic, Inc.Hologic, Inc.

Hologic, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

HOLX trade ideas

Hologic, Inc. - [HOLX]Trend Analysis : Current Price: $81.24. Recent Trend: The price has been in an uptrend from mid-June 2024 after a decline from the high in early May 2024. Short-Term Trend: The price is currently correcting within the uptrend, with recent candles showing potential consolidation around the $80-82 range. Bollinger Bands : Upper Band: The price has recently touched the upper band and has started pulling back. Middle Band (SMA): The price is currently above the middle band, which typically suggests the uptrend is intact. Lower Band: The lower band is below the $75 level, offering potential support in case of a correction. Support and Resistance : Immediate Support: Around $80, where the price has consolidated in recent candles. Immediate Resistance: The recent high near $84.67. Additional Resistance: The upper Bollinger Band, which currently sits around $85. Potential Support: The middle Bollinger Band and previous consolidation zone around $76-$78. Volume Analysis : The volume has been relatively stable with no significant spikes, suggesting that the recent uptrend may not be strongly driven by high demand. A spike in volume could indicate stronger momentum in either direction. Candlestick Patterns : Recent candles show smaller bodies with shadows, indicating indecision in the market, which often precedes a stronger move. A breakout above $84 with strong volume could signify continuation of the uptrend. A breakdown below $80 could suggest a deeper correction towards the middle Bollinger Band. Summary : The stock is in an uptrend but currently faces resistance near $84.67. The next move could depend on whether the price can break above this resistance or if it pulls back to test support near $80. Watch for a breakout with increased volume as an indicator of further upward momentum. Conversely, a breakdown below $80 could lead to a pullback towards the $76-$78 region.
NASDAQ:HOLXLong
by Sahrin
Hologic: Holding Above 200-week SMA Inside of a Cup with HandleHologic is currently Consolidating within the potential handle of a Bullish Cup with Handle pattern and is holding above the 200-week Simple Moving Average. If this pattern plays out successfully, the measured move target would take HOLX up to around $118. n addition to the technical pattern, HOLX seems to be improving its balance sheet on an annual basis, consistently increasing Assets while decreasing Liabilities and Debts. Overall, this stock seems like a stronger stock within the health sector.
NASDAQ:HOLXLong
by RizeSenpai
Hologic's (HOLX:NASDAQ) Strong Fundamentals Post-CovidHologic, a leading company in the healthcare sector, continues to display appealing business economics and robust fundamentals, even after the Covid pandemic. In this analysis, we delve into additional critical factors contributing to its attractiveness, such as positive sentiment and price studies. Based on the culmination of these studies, investors appear bullish on HOLX, leading to a reiteration of a "buy" recommendation. 1. Resilient Business Economics Despite the challenges posed by the Covid pandemic, Hologic has demonstrated resilient business economics. The company's ability to navigate through the pandemic and maintain its operational strength has instilled confidence among investors and analysts. 2. Strong Fundamentals Post-Covid Hologic's fundamentals have remained strong after the Covid pandemic, with key financial indicators reflecting a stable and healthy position. This signals the company's ability to adapt and perform well in a dynamic market environment. 3. Positive Sentiment Investors' sentiment towards Hologic has been notably positive, driven by the company's consistent performance and growth prospects. Positive sentiment often indicates market confidence in the company's long-term potential. 4. Price Studies In-depth price studies conducted on Hologic's stock have revealed favorable trends and patterns, further contributing to its appeal. The analysis of price movements and technical indicators offers valuable insights into the stock's potential future trajectory. 5. Bullish Outlook Considering the combination of positive sentiment, robust fundamentals, and encouraging price studies, investors have adopted a bullish stance on Hologic's stock. This optimism reflects a belief in the company's ability to deliver sustained growth and value for shareholders. Conclusion Hologic remains an attractive prospect in the healthcare sector, boasting resilient business economics and strong fundamentals even post-Covid. Positive sentiment among investors and encouraging price studies further contribute to the company's appeal. As a result, investors have expressed a bullish outlook on HOLX, leading to a reiteration of a "buy" recommendation for potential investors looking to capitalize on the company's promising future prospects. As always, investors should conduct their due diligence and carefully assess their investment objectives before making any financial decisions. This content is provided for general information purposes only and is not to be taken as investment advice nor as a recommendation for any security, investment strategy or investment account.
NASDAQ:HOLXLong
by CapitalMarketsEliteGroup
Hologic IncHologic Inc is a developer, manufacturer, and supplier of diagnostics products, medical imaging systems, and surgical products focused on women’s health and well-being through early detection and treatment. The stock is listed on the Nasdaq Stock Exchange. The price chart formed an 11-month-long rectangle with the horizontal boundary acting as strong support around the $67.70 level. A daily close below the $66.30 level will confirm the breakdown from the 11-month-long rectangle with a possible chart pattern price target around the $57.00 level.
NASDAQ:HOLXShort
by Chonkalonka
Bottom FishingYearly low is 49.19. Yearly high is 85. Bearish divergence at top, and it is an ugly top! HOLX also fell from a series of bearish rising wedges that I did not draw as at this point they are not as significant. Struggling to say the least and the moving averages are screwed up and out of place. Only the 200 is still sloping up which is the longest term moving average I use. The 50 just crossed down and through the 200 which some refer to as a death cross. Large Volume noted in the past week or so of trading. This plateau may not be for real but price has formed a horizontal trading zone and a stop around 61 would put you below the prior low It looks like the first drop down was followed by a brief rise up which was most likely a bear flag. Bear flags/pennants can mark the half way pint in a fall, but not always. There is a pocket pivot below price. I like pocket pivots (o: This has pulled back very close to the 1.13 but is definitely still in the woods for now. This can drop suddenly, especially when it is nearing the top. I guess any stock can though. I trade this one over and over because I am familiar with how it moves. Sometimes picking a basket of stocks and trading them over and over can be beneficial because you can begin to know how they move. No recommendation. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts. EPS (FWD) 7.62 PE (FWD) 8.23
NASDAQ:HOLX
by lauralea
HOLX - Good entry based on future expectationsHOLX is company that has gone through a good 2020 FY with Gross Margins, EBITDA and Cash Flow from operations growing materially. In the last quarter (Q1'21 for HOLX given that FY ends on SEP'20), EPS increased strongly (+369%) coupled with strong sales increase (+89%). This sets a good tone for the rest of the FY'21. The company is also growing through a set of diversified acquisitions. The current PE ratio is also attractive. The recent market shake-off could be a good entry point, in case no further heavy market stress is experienced in the short-term.
NASDAQ:HOLXLong
by HR_D
HOLX - 18.87% Potential Profit - Bullish PennantBullish Pennant formed after a 9-month run. Multiple new support confirmation over the past few days. I am being quite conservative with the Stop Loss. You can place it to $76.59 if your appetite for risk is higher. - Target Entry $80.50 - Target Stop Loss $79.22 - Target Exit $94.00 About me - P/L September +49.18% | August: +232.32% | No Trades without Analysis - Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be achieved as long as there are no strong pullbacks that trigger my new adjusted stop loss
NASDAQ:HOLXLong
by maschera